CN Patent

CN106279017A — 贝达喹啉晶型、组合物及其制备方法

Assigned to Chongqing Changjie Medicine Chemical Co ltd · Expires 2017-01-04 · 9y expired

What this patent protects

本发明提供一种贝达喹啉富马酸盐的晶型I，该晶型稳定性好，适宜制备成多种制剂。本发明提供包含上述贝达喹啉晶型I的药用组合物，该组合物质量稳定，适应性好。本发明提供上述贝达喹啉晶型I的制备方法，该方法简单，工业实用性强。

USPTO Abstract

本发明提供一种贝达喹啉富马酸盐的晶型I，该晶型稳定性好，适宜制备成多种制剂。本发明提供包含上述贝达喹啉晶型I的药用组合物，该组合物质量稳定，适应性好。本发明提供上述贝达喹啉晶型I的制备方法，该方法简单，工业实用性强。

Drugs covered by this patent

Patent Metadata

Patent number
CN106279017A
Jurisdiction
CN
Classification
—
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Changjie Medicine Chemical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.